You Are Here:
Clinical Summary of U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2009 recommendation of the U.S. Preventive Services Task Force (USPSTF) on screening for skin cancer. This summary is intended for use by primary care clinicians.
Select for copyright and source information.
|Population||Adult General Population1|
|"I" Statement: Insufficient Evidence||No recommendation due to insufficient evidence|
|Suggestions for Practice||
Clinicians should remain alert for skin lesions with malignant features that are noted while performing physical examinations for other purposes. Features associated with increased risk for malignancy include: asymmetry, border irregularity, color variability, diameter >6mm ("A," "B," "C," "D"), or rapidly changing lesions. Suspicious lesions should be biopsied.
|Other Relevant Recommendations from the USPSTF and the U.S. Task Force on Community Preventive Services||
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents please go to http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Copyright and Source Information
This document is in the public domain within the United States.
Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.
AHRQ Publication No. 09-05128-EF-3
Current as of February 2009
U.S. Preventive Services Task Force. Screening for Skin Cancer: Clinical Summary of U.S. Preventive Services Task Force Recommendation. AHRQ Publication No. 09-05128-EF-3, February 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://www.uspreventiveservicestaskforce.org/uspstf09/skincancer/skincansum.htm